Skip to main content

Table 2 Correlations between sPD-L1 and clinicopathological features in patients with metastatic colorectal cancer

From: Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer

 

N

High N (%)

Low N (%)

p-value

Gender

   

0.735

 Male

82

28 (46.34)

44 (53.66)

 

 Female

42

23 (54.76)

19 (45.24)

 

Age

   

0.879

  ≤ 60

52

26 (50.00)

26 (50.0)

 

  > 60

72

35 (48.61)

37 (51.39)

 

Metastasis

   

0.347

 Synchronous

111

53 (47.75)

58 (52.25)

 

 Metachronous

13

8 (61.54)

5 (38.46)

 

Location of primary

   

0.187

 Right

34

20 (58.82)

14 (41.18)

 

 Left

90

41 (45.56)

49 (54.44)

 

Numbers of metastatic sites

   

0.080

 1

92

41 (44.57)

51 (55.43)

 

  ≥ 2

32

20 (62.50)

12 (37.50)

 

Liver metastasis

   

0.809

 Yes

80

40 (50.00)

40 (50.00)

 

 No

44

21 (47.73)

23 (52.27)

 

Lung metastasis

   

0.809

 Yes

29

13 (44.83)

16 (55.17)

 

 No

95

48 (50.53)

47 (49.47)

 

Peritoneum metastasis

   

0.157

 Yes

26

16 (61.54)

10 (38.46)

 

 No

98

45 (45.92)

53 (54.08)

 

Lymph node metastasis

   

0.030

 Yes

23

16 (69.57)

7 (30.43)

 

 No

101

45 (44.55)

56 (55.45)

 
  1. Bold refers p < 0.05 with statistical significance
  2. Bold italic refers p > 0.05 but < 0.10 with potentially statistical significance